EA202192397A3 - INTRANASAL BIOADHESIVE TESTOSTERONE COMPOSITIONS IN THE FORM OF GELS AND THEIR USE FOR THE TREATMENT OF MALE HYPOGONADISM - Google Patents

INTRANASAL BIOADHESIVE TESTOSTERONE COMPOSITIONS IN THE FORM OF GELS AND THEIR USE FOR THE TREATMENT OF MALE HYPOGONADISM

Info

Publication number
EA202192397A3
EA202192397A3 EA202192397A EA202192397A EA202192397A3 EA 202192397 A3 EA202192397 A3 EA 202192397A3 EA 202192397 A EA202192397 A EA 202192397A EA 202192397 A EA202192397 A EA 202192397A EA 202192397 A3 EA202192397 A3 EA 202192397A3
Authority
EA
Eurasian Patent Office
Prior art keywords
testosterone
treatment
intranasal
gels
male hypogonadism
Prior art date
Application number
EA202192397A
Other languages
Russian (ru)
Other versions
EA202192397A2 (en
Inventor
Уэйн Креппнер
Шивон Фогарти
Вернер Обереггер
Пол Хосе Пьер Мари Маэс
Original Assignee
Эйсерус Биофарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйсерус Биофарма Инк. filed Critical Эйсерус Биофарма Инк.
Publication of EA202192397A2 publication Critical patent/EA202192397A2/en
Publication of EA202192397A3 publication Critical patent/EA202192397A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к перназальным биоадгезивным тестостероновым составам в виде гелей для интраназального введения и способам заместительной терапии тестостероном для применения указанных перназальных тестостероновых биоадгезивных составов в виде гелей с обеспечением замедленной интраназальной доставки тестостерона у мужчин с дефицитом тестостерона для лечения, например субъектов мужского пола с диагностированным гипогонадизмом.The invention relates to intranasal testosterone bioadhesive gel formulations for intranasal administration and methods of testosterone replacement therapy for administering said pernasal testosterone bioadhesive gel formulations to provide delayed intranasal testosterone delivery in men with testosterone deficiency for treatment, e.g., male subjects diagnosed with hypogonadism.

EA202192397A 2011-05-16 2012-05-15 INTRANASAL BIOADHESIVE TESTOSTERONE COMPOSITIONS IN THE FORM OF GELS AND THEIR USE FOR THE TREATMENT OF MALE HYPOGONADISM EA202192397A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161486634P 2011-05-16 2011-05-16

Publications (2)

Publication Number Publication Date
EA202192397A2 EA202192397A2 (en) 2021-12-31
EA202192397A3 true EA202192397A3 (en) 2022-03-31

Family

ID=80631211

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202192397A EA202192397A3 (en) 2011-05-16 2012-05-15 INTRANASAL BIOADHESIVE TESTOSTERONE COMPOSITIONS IN THE FORM OF GELS AND THEIR USE FOR THE TREATMENT OF MALE HYPOGONADISM
EA201391703A EA039080B1 (en) 2011-05-16 2012-05-15 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201391703A EA039080B1 (en) 2011-05-16 2012-05-15 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism

Country Status (1)

Country Link
EA (2) EA202192397A3 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258694T3 (en) * 2003-11-11 2006-09-01 Mattern, Udo ADMINISTRATION SYSTEM FOR CONTROLLED RELEASE OF SEX HORMONES FOR NASAL APPLICATIONS.
EP2191833B1 (en) * 2007-09-20 2013-02-13 Shiseido Company, Ltd. Transdermally absorbable preparation

Also Published As

Publication number Publication date
EA202192397A2 (en) 2021-12-31
EA201391703A1 (en) 2016-01-29
EA039080B1 (en) 2021-12-01

Similar Documents

Publication Publication Date Title
CY1124311T1 (en) DNA-PK INHIBITORS
CY1124499T1 (en) LIPIDS FOR THERAPEUTIC AGENT DELIVERY COMPOSITIONS
CY1121882T1 (en) PYRAZOLYL QUINOXALINE KINASE INHIBITORS
EA201390803A1 (en) Bromodomain inhibitors and their use
EA201492055A1 (en) INHALATIVE DELIVERY OF mRNA IN TIGHTNESS CELL TARGETS
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
GT201400057A (en) 3-PIRMIDIN-4-IL-OXAZOLIDIN-2-ONAS AS INHIBITORS OF THE MUTANT HDI
HN2011003011A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
GB201118656D0 (en) New compounds
MX2019013670A (en) Antibody and protein formulations.
EA201590667A1 (en) ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES
EA201992133A1 (en) PIPERIDINO-PYRIMIDINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
TN2012000465A1 (en) Derivatives of 1-amino-2-cyclopropylethylboronic acid
IN2014MN00986A (en)
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
EA201370018A1 (en) COMPOSITIONS OF RIFAXIMINE AND THEIR APPLICATION
IN2014DN10386A (en)
EA201391154A3 (en) METHODS AND COMPOSITIONS FOR ADISCING TO ADIPOCYTES IN MAMMALS
NZ707778A (en) Therapeutic compounds and compositions and their use as pkm2 modulators
MX2013004061A (en) Cyclosporin analogs.
ATE528013T1 (en) VACCINE COMPOSITIONS
EA201391702A1 (en) INTRANASAL TESTOSTERONIC COMPOSITIONS WITH REDUCED DOSAGE IN THE FORM OF GEL AND THEIR USE FOR THE TREATMENT OF ANORGASMASIS OR HYPOACTIVE DISORDER
BR112016006064A2 (en) pro-dentifrice composition, glycerin based composition, and oral mucosa therapy kit
MX2013004062A (en) Cyclosporin analogs.
MX2018007871A (en) Personal care composition comprising taurine, arginine, glycine.